The Medicines Company: Investor & Analyst Day (The Medicines Company) - Nov 8, 2014 - Anticipated initiation of P2 dose finding trial for atherosclerosis in Q2 2015; Anticipated data for P2 dose finding trial for atherosclerosis in Q2 2016; Anticipated publication of P1 data for atherosclerosis in Q1 2015
Anticipated new P2 trial • Anticipated P1 data • Anticipated P2 data • Dyslipidemia
|